Reltic Pharmaceutical Private Limited
About Reltic Pharmaceutical Private Limited
Data last updated:
Reltic Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC339581. Its GSTIN is 07AAJCR1804K1ZB (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Prashant Kumar Gupta and Geetika Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 301 Third Floor Plot No. 18 Lsc Madangir Pushp Vihar, Delhi, India – 110062.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.7 Lakh. For the same year it recorded a net profit of ₹3.82 Lakh (net margin 22.9%) and EBITDA of ₹5.17 Lakh (EBITDA margin 31%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Reltic Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 301 Third Floor Plot No. 18 Lsc Madangir Pushp Vihar, Delhi, India – 110062
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Reltic Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reltic Pharmaceutical Private Limited
FY 2025 filings availableReltic Pharmaceutical Private Limited reported revenue of ₹16.7 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31% | ||||
| Net Profit Margin | 22.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reltic Pharmaceutical Private Limited, buy the company report.
Board of directors of Reltic Pharmaceutical Private Limited
Reltic Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Kumar Gupta Also directs: Reltic Enterprises Private Limited, Jeevan Pratham Foundation | Director | 27 Sep 2018 | 8 Years 1 Months | Current |
| Krish Gupta | Additional Director | 13 Aug 2024 | 2 Years 2 Months | Current |
| Geetika Gupta | Director | 15 Sep 2021 | 5 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Reltic Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reltic Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reltic Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCR1804K1ZB | Delhi | Active | 14 Feb 2019 |
To see the full GST registrations and return filing status of Reltic Pharmaceutical Private Limited, buy the company report.
Recent activity
Reltic Pharmaceutical Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Krish Gupta was appointed as Additional Director on 13 Aug 2024.
Frequently asked questions
Reltic Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 September 2018 (8+ years old) and is registered under CIN U51909DL2018PTC339581.
Reltic Pharmaceutical has 3 current directors:
- Prashant Kumar Gupta - Director
- Krish Gupta - Additional Director
- Geetika Gupta - Director
The latest financial statements of Reltic Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Reltic Pharmaceutical is 07AAJCR1804K1ZB, registered in Delhi.
The CIN (Corporate Identification Number) of Reltic Pharmaceutical is U51909DL2018PTC339581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reltic Pharmaceutical was incorporated on 27 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Krish Gupta was appointed as Additional Director on 13 Aug 2024. Geetika Gupta was appointed as Director on 15 Sep 2021. Neetu Sabarwal ceased to be Director on 15 Sep 2021. Reltic Pharmaceutical has 5 board changes on record in total.
The registered office of Reltic Pharmaceutical is at Flat No. 301 Third Floor Plot No. 18 Lsc Madangir Pushp Vihar, Delhi, India – 110062.
Reltic Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Reltic Pharmaceutical is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.